Re: Symptomatic bilateral delayed partial ureteral obstruction after bilateral endoscopic correction of vesicoureteral reflux with dextranomer/hyaluronic acid polymer.
Douglas A
DA
Canning
D003911:Dextrans / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000009:adverse effects*; D014517:Ureteral Obstruction / Q000209:etiology*; D014718:Vesico-Ureteral Reflux / Q000628:therapy*
D003911:Dextrans; D006820:Hyaluronic Acid